Document is current
Any future updates will be listed below
-
Authors
Tsiami, Foteini
Drwesh, Layla
Surender, Surender
Fitzgerald, Julia
Schittenhelm, Jens
Picketts, David J.
Segal, Rosalind A.
Tabatabai, Ghazaleh
Merk, Daniel J.
-
Funding
Funding for this research was provided by:
Eberhard Karls Universität Tübingen
- License Information
-
More Information
Article History
Received: 16 September 2024
Accepted: 14 July 2025
First Online: 18 July 2025
Declarations
:
: Ghazaleh Tabatabai has served on advisory boards (Bayer, Boehringer Ingelheim, CureVac, Miltenyi Biomedicine, Novocure), as a consultant (Bayer, Boehringer Ingelheim, CureVac), as steering committee member in non-interventional trials (Bayer, Novocure), as a speaker (Novocure, Servier), and financial compensation for all these activities was provided as institutional funding to the University Hospital Tübingen. All other authors declare no competing interests.
